The efficacy and safety profile of anlotinib with etoposide plus cisplatin/carboplatin in treatment-naive extensive-stage small cell lung cancer(SCLC) patients: Results from a phase II single-arm trial.

Pengbo Deng,Huaping Yang,Cen Chen,Chengping Hu,Liming Cao,Qihua Gu,Jian An,Bin Li,Yongjun Tang,Jie Meng,Juntao Feng

The efficacy and safety profile of anlotinib with etoposide plus cisplatin/carboplatin in treatment-naive extensive-stage small cell lung cancer(SCLC) patients: Results from a phase II single-arm trial.

2020

Pengbo Deng
Huaping Yang
Cen Chen
Chengping Hu
Liming Cao
Qihua Gu
Jian An
Bin Li
Yongjun Tang
Jie Meng
Juntao Feng

9066Background: Combination of etoposide and cisplatin/carboplatin is the most commonly used initial chemoptherapy regiment in extensive-stage small cell lung cancer. A meta-analysis released that,...

Keywords:

Cisplatin
Oncology
therapy naive
Carboplatin
Pathology
Internal medicine
Extensive-stage small cell lung cancer
Medicine
Etoposide
safety profile

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations